Image for representational purposes only. | Photo Credit: The Hindu Bharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at ₹800 (excluding GST) for private markets and ₹325 (excluding GST) for government supplies. A press release from the vaccine maker said the jab … Read more
Bharat Biotech International Ltd on Friday said its COVID-19 vaccine Covaxin has proven to be safe, well-tolerated and highly immunogenic in children and adolescents of 2-18 years age group in phase II/III study. The company conducted phase II/III, open-label, and multicentre study to evaluate the safety, reactogenicity and immunogenicity of Covaxin in healthy children and … Read more
The Coalition for Epidemic Preparedness Innovations (CEPI) on Tuesday announced a $200-million programme for the development of vaccines that provide broad protection against SARS-CoV-2 variants and other beta coronaviruses. CEPI will provide funding of up to $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to an international multi-disciplinary consortium comprising Bharat … Read more
A day after slashing the price of the precaution dose of Covishield to Rs 225 per shot for private hospitals, the Serum Institute of India (SII) told the Centre on Sunday that it will compensate for the price difference for the unexpired stocks lying with private centres in the form of free vials of fresh … Read more
A day before the Covid-19 booster shoot drive is rolled out, both major vaccine manufacturers went on to announce a massive price cut on their vaccines. The Covid-19 vaccines Covishied which is manufactured by the Serum Institute of India and Covaxin from Bharat Biotech earlier used to cost Rs 600 and Rs 1200 respectively, but … Read more
In the light of the World Health Organisation (WHO)’s move to suspend supply of Covaxin produced by Hyderabad- headquartered Bharat Biotech, through UN procurement agencies, those in the Indian vaccine industry feel the focus will now increasingly be on the Indian drug regulator – the office of the Drugs Controller General of India (DCGI) and … Read more
The World Health Organization (WHO) has confirmed it has suspended the supply of Covaxin, produced by city-based Bharat Biotech, through UN procurement agencies and recommending to countries that received the covid vaccine to take actions as appropriate. A statement issued by WHO on Saturday said the suspension is in response to the outcomes of its … Read more
Biofabri is a biopharmaceutical company of Zendal group based in Porriño, Spain, with the aim of researching, developing and manufacturing vaccines for humans. The vaccine would be manufactured and developed by Biofabri in collaboration with the University of Zaragoza, IAVI and the Tuberculosis Vaccine Initiative (TBVI). Bharat Biotech on Wednesday announced a partnership with Spain’s … Read more
India is yet to approve the use of intranasal vaccine against COVID-19, BBV154 developed by the Hyderabad based company. The AIIMS will start the booster dose trial of Bharat Biotech’s intranasal COVID-19 vaccine from Friday. The booster dose will be given to those who have received both the doses of either Covaxin or Covishield at … Read more
Covaxin (BBVI52), which has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is an investigational vaccine candidate product in the US. Bharat Biotech on Saturday said its Covaxin will be evaluated as a COVID-19 vaccine candidate in the US. In a statement, Ocugen Inc, Bharat Biotech’s partner in … Read more